MARLBOROUGH, Mass.,
Jan. 22, 2018 /PRNewswire/ --
Hologic's (Nasdaq: HOLX) Cynosure division announced today the
launch of TempSure™ Envi – an FDA-cleared advanced
radiofrequency device that minimizes facial fine lines and
wrinkles, tightens skin through soft tissue coagulation, and
improves the appearance of cellulite.
TempSure™ Envi is a simpler way for patients to
maintain beautiful skin. The device heats the deep layers of skin
to regenerate collagen and improve the appearance of cellulite and
wrinkles associated with forehead lines, frown lines, crow's feet,
smile lines and wrinkles on the chin. Treatments are safe for all
skin types and require no downtime, lasting between 30 and 60
minutes based on the area treated.
Unlike other radiofrequency devices, TempSure™ Envi
has the distinct advantage of Therapeutic Logic Control (TLC) – a
system that links treatment time with target temperature, allowing
for consistent treatment temperatures and high patient comfort
levels. In fact, 99% of patients who participated in a Cynosure
in-house study reported a pain-free treatment experience.
"With a customer base looking to diversify their specialty
offerings beyond laser and injectable treatments, we are
enthusiastic about the opportunity to provide a radiofrequency
platform as effective and versatile as TempSure™
Envi," said Kevin Thornal, Hologic's
Division President, Cynosure. "We also look forward to a variety of
future TempSure™ FDA clearances including surgical and
women's health capabilities, among others, meeting additional
critical customer needs."
TempSure™ Envi treatments will be demonstrated at
this year's American Academy of Dermatology meeting in San Diego (February 16
to 18). To learn more about TempSure™ Envi,
please visit www.cynosure.com/tempsure.
About Hologic, Inc.
Hologic, Inc. is an innovative
medical technology company primarily focused on improving women's
health and well-being through early detection and treatment.
For more information on Hologic, visit www.hologic.com.
Hologic, The Science of Sure, Cynosure and TempSure Envi are
trademarks and/or registered trademarks of Hologic, Inc. and/or its
subsidiaries in the United States
and/or other countries.
Forward-Looking Statements
This news release may
contain forward-looking information that involves risks and
uncertainties, including statements about the use of Hologic
products. There can be no assurance these products will achieve the
benefits described herein or that such benefits will be replicated
in any particular manner with respect to an individual patient, as
the actual effect of the use of the products can only be determined
on a case-by-case basis. In addition, there can be no assurance
that these products will be commercially successful or achieve any
expected level of sales. Hologic expressly disclaims any obligation
or undertaking to release publicly any updates or revisions to any
such statements presented herein to reflect any change in
expectations or any change in events, conditions or circumstances
on which any such data or statements are based.
Media Contact:
Jane
Mazur
508.263.8764 (direct)
585.355.5978 (mobile)
jane.mazur@hologic.com
Investor Contact:
Michael
Watts
858.410.8588
michael.watts@hologic.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/hologics-cynosure-division-launches-tempsure-envi-300585528.html
SOURCE Hologic